Dr. Jason Lee was the first to publish on gabapentin in idiopathic chronic cough, dupilumab use in CSU, dupilumab use in IgG4 related disease. His clinic in Toronto currently serves over 1,200 patients on biologics for immunologic conditions. He obtained his doctor of medicine degree from the University of Toronto, internal medicine at the University of British Columbia, a fellowship in clinical immunology and allergy at the University of Toronto. Dr. Lee is the immediate past section head of asthma at the CSACI and current member of the ACAAI biologics and therapeutics executive.